소 헬스케어 시장 : 제품 유형별, 최종 사용자별, 지역별(2025-2033년)

The global cattle healthcare market size reached USD 9.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.5 Billion by 2033, exhibiting a growth rate (CAGR) of 3.44% during 2025-2033. The augmenting demand for animal protein, expanding disposable income levels, and increasing prevalence of zoonotic diseases represent some of the key factors driving the market.

Cattle healthcare refers to the management of all aspects of the physical and mental health of cattle. It involves preventing, diagnosing, and treating health issues in order to maintain the well-being and productivity of the animals. The primary objectives of cattle healthcare include preventing the spread of diseases, ensuring optimal nutrition and growth, providing a safe and clean environment, and implementing effective disease control measures. Regular monitoring and evaluation of the herd's health are essential for the early detection and treatment of potential health issues. Effective cattle healthcare requires a combination of good management practices, veterinary care, and appropriate use of medications. This may include vaccination programs, parasite control, nutritional management, and disease surveillance programs. Moreover, implementing proper cattle healthcare practices can improve animal welfare, enhance productivity, and promote sustainability in the livestock industry.

Cattle Healthcare Market Trends:

One of the primary factors driving the market is the augmenting demand for animal protein due to the growing population globally. Additionally, on account of the expanding disposable income levels of the masses, there is a rise in the production of livestock, including cattle, thus creating a positive market outlook. Other than this, the increasing prevalence of zoonotic diseases, such as bovine tuberculosis, brucellosis, and salmonellosis, is creating a greater emphasis on animal health and disease control measures. Besides this, the rising awareness among livestock producers regarding the importance of animal health and welfare to ensure the sustainability of their operations is positively influencing market growth. In line with this, the exponential growth in the dairy industry, specifically in emerging economies, is propelling the market growth. Apart from these factors, the increasing investment in livestock production is leading to increased demand for cattle healthcare products and services to support the industry. Furthermore, the growing environmental concerns have led to an increasing focus on cattle healthcare products and services that promote sustainable livestock production. Moreover, governments across the world are taking initiatives to promote animal health and welfare, such as disease surveillance programs, vaccination campaigns, and regulations, to ensure the safe and ethical use of veterinary drugs. Furthermore, significant technological advancements are leading to the development of new and innovative cattle healthcare products and services, such as vaccines, tests, and medicines, thus creating a positive market outlook.

Key Market Segmentation:

Product Type Insights:

• Vaccines
• Pharmaceuticals
• Analgesics
• Anti-infective
• Anti-inflammatory
• Parasiticides
• Others
• Feed additives
• Medicinal
• Nutritional

End User Insights:

• Dairy farms
• Veterinary hospitals
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cattle healthcare. Some of the factors driving the North America cattle healthcare market included increasing demand for animal protein, technological advancements in veterinary medicine, and rising awareness of animal welfare.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global cattle healthcare market. Detailed profiles of all major companies have also been provided. Some of the companies covered include BioZyme Inc., Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn AG & Co. KG), Ceva Sante Animate, Elanco Animal Health Incorporated, Merck & Co. Inc., Virbac, Zoetis Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

• 1. How big is the global cattle healthcare market?
• 2. What is the expected growth rate of the global cattle healthcare market during 2025-2033?
• 3. What are the key factors driving the global cattle healthcare market?
• 4. What has been the impact of COVID-19 on the global cattle healthcare market?
• 5. What is the breakup of the global cattle healthcare market based on the end user?
• 6. What are the key regions in the global cattle healthcare market?
• 7. Who are the key players/companies in the global cattle healthcare market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Cattle Healthcare Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Vaccines
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Pharmaceuticals
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Analgesics
    • 6.2.2.2 Anti-Infective
    • 6.2.2.3 Anti-Inflammatory
    • 6.2.2.4 Parasiticides
    • 6.2.2.5 Others
  • 6.2.3 Market Forecast
• 6.3 Feed Additives
  • 6.3.1 Market Trends
  • 6.3.2 Key Segments
    • 6.2.2.1 Medicinal
    • 6.2.2.2 Nutritional
  • 6.3.3 Market Forecast

7 Market Breakup by End User

• 7.1 Dairy Farms
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Veterinary Hospitals
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

• 9.1 Overview
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 BioZyme Inc.
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn AG & Co. KG)
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 Ceva Sante Animale
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Elanco Animal Health Incorporated
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
  • 13.3.5 Merck & Co. Inc.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
    • 13.3.5.4 SWOT Analysis
  • 13.3.6 Virbac
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
    • 13.3.6.4 SWOT Analysis
  • 13.3.7 Zoetis Inc.
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.